Building a regional pharmacovigilance platform for LATAM
Summary
Building Iris LLC's regional pharmacovigilance platform, launching in Iris Global Ecuador under ARCSA's new standard (Nov 4, 2026) and next in Iris Mexico. The design keeps the audit outside the model: every case runs one 7-stage workflow with a human gate before anything reaches the regulator, access is by role, and every action lands in an append-only audit trail and evidence pack. AI is sequenced after go-live, to prepare and suggest, never to decide or sign.
Skills Demonstrated
Impact
- Developed a regional pharmacovigilance platform for Iris LLC, launching in Iris Global Ecuador by Nov 4, 2026, and subsequently in Iris Mexico.